{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,4]],"date-time":"2025-11-04T10:38:55Z","timestamp":1762252735602},"reference-count":16,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2018,7,1]],"date-time":"2018-07-01T00:00:00Z","timestamp":1530403200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,5,7]],"date-time":"2018-05-07T00:00:00Z","timestamp":1525651200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Saudi Journal of Biological Sciences"],"published-print":{"date-parts":[[2018,7]]},"DOI":"10.1016\/j.sjbs.2018.05.010","type":"journal-article","created":{"date-parts":[[2018,5,7]],"date-time":"2018-05-07T13:13:03Z","timestamp":1525698783000},"page":"982-985","update-policy":"http:\/\/dx.doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"title":["MicroRNA-4728 serves as a suppressor and antagonist of oncogenic MAPK in Burkitt lymphoma"],"prefix":"10.1016","volume":"25","author":[{"given":"Wei","family":"Wang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Peng","family":"Lin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Haiying","family":"Yao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xi","family":"Jia","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jirui","family":"Sun","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lin","family":"Feng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.sjbs.2018.05.010_b0005","doi-asserted-by":"crossref","first-page":"15524","DOI":"10.1073\/pnas.242606799","article-title":"Frequent deletions and down-regulation of micro-RNA genes miR15 and miR16 at 13q14 in chronic lymphocytic leukemia","volume":"99","author":"Calin","year":"2002","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.sjbs.2018.05.010_b0010","doi-asserted-by":"crossref","first-page":"3279","DOI":"10.1038\/sj.onc.1210421","article-title":"MAP kinase signalling pathways in cancer","volume":"26","author":"Dhillon","year":"2007","journal-title":"Oncogene"},{"key":"10.1016\/j.sjbs.2018.05.010_b0015","doi-asserted-by":"crossref","first-page":"1782","DOI":"10.1182\/blood-2012-05-402784","article-title":"The role of miRNAs in the pathogenesis and diagnosis of B-cell lymphomas","volume":"120","author":"Di Lisio","year":"2012","journal-title":"Blood"},{"key":"10.1016\/j.sjbs.2018.05.010_b0020","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1002\/emmm.201100209","article-title":"MicroRNA dysregulation in cancer: diagnostics, monitoring and therapeutics. A comprehensive review","volume":"4","author":"Iorio","year":"2012","journal-title":"EMBO Mol. Med."},{"key":"10.1016\/j.sjbs.2018.05.010_b0025","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1038\/nrc3166","article-title":"Epigenetics and genetics. MicroRNAs en route to the clinic: progress in validating and targeting microRNAs for cancer therapy","volume":"11","author":"Kasinski","year":"2011","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.sjbs.2018.05.010_b0030","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1002\/gcc.20273","article-title":"Lack of BIC and microRNA miR-155 expression in primary cases of Burkitt lymphoma","volume":"45","author":"Kluiver","year":"2006","journal-title":"Genes Chromosomes Cancer"},{"key":"10.1016\/j.sjbs.2018.05.010_b0035","doi-asserted-by":"crossref","first-page":"807","DOI":"10.3233\/CBM-150524","article-title":"MiR-4728-3p could act as a marker of HER2 status","volume":"15","author":"Li","year":"2015","journal-title":"Cancer Biomark"},{"key":"10.1016\/j.sjbs.2018.05.010_b0040","doi-asserted-by":"crossref","first-page":"834","DOI":"10.1038\/nature03702","article-title":"MicroRNA expression profiles classify human cancers","volume":"435","author":"Lu","year":"2005","journal-title":"Nature"},{"key":"10.1016\/j.sjbs.2018.05.010_b0045","doi-asserted-by":"crossref","first-page":"1775","DOI":"10.1089\/ars.2006.8.1775","article-title":"Reactive oxygen species-induced activation of the MAP kinase signaling pathways","volume":"8","author":"McCubrey","year":"2006","journal-title":"Antioxid Redox Signal"},{"key":"10.1016\/j.sjbs.2018.05.010_b0050","doi-asserted-by":"crossref","first-page":"1381","DOI":"10.1517\/14712598.2015.1074999","article-title":"MicroRNAs in cancer therapeutics: \u201cfrom the bench to the bedside\u201d","volume":"15","author":"Monroig-Bosque Pdel","year":"2015","journal-title":"Expert Opin. Biol. Ther."},{"key":"10.1016\/j.sjbs.2018.05.010_b0055","doi-asserted-by":"crossref","first-page":"e97200","DOI":"10.1371\/journal.pone.0097200","article-title":"The HER2-encoded miR-4728-3p regulates ESR1 through a non-canonical internal seed interaction","volume":"9","author":"Newie","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.sjbs.2018.05.010_b0060","doi-asserted-by":"crossref","first-page":"1328","DOI":"10.1097\/MIB.0000000000001104","article-title":"miR-4728-3p functions as a tumor suppressor in ulcerative colitis-associated colorectal neoplasia through regulation of focal adhesion signaling","volume":"23","author":"Pekow","year":"2017","journal-title":"Inflamm Bowel Dis."},{"key":"10.1016\/j.sjbs.2018.05.010_b0065","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1158\/0008-5472.CAN-10-1869","article-title":"Identification of new microRNAs in paired normal and tumor breast tissue suggests a dual role for the ERBB2\/Her2 gene","volume":"71","author":"Persson","year":"2011","journal-title":"Cancer Res."},{"key":"10.1016\/j.sjbs.2018.05.010_b0070","doi-asserted-by":"crossref","first-page":"e1742","DOI":"10.1038\/cddis.2015.116","article-title":"ErbB2-intronic microRNA-4728: a novel tumor suppressor and antagonist of oncogenic MAPK signaling","volume":"6","author":"Schmitt","year":"2015","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.sjbs.2018.05.010_b0075","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1111\/j.1349-7006.2006.00244.x","article-title":"ERK MAP kinase in G cell cycle progression and cancer","volume":"97","author":"Torii","year":"2006","journal-title":"Cancer Sci."},{"key":"10.1016\/j.sjbs.2018.05.010_b0080","doi-asserted-by":"crossref","first-page":"5404","DOI":"10.4049\/jimmunol.1402933","article-title":"MicroRNA-26b modulates the NF-kappaB pathway in alveolar macrophages by regulating PTEN","volume":"195","author":"Zhang","year":"2015","journal-title":"J. Immunol."}],"container-title":["Saudi Journal of Biological Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1319562X18301219?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1319562X18301219?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,6,29]],"date-time":"2018-06-29T17:51:22Z","timestamp":1530294682000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1319562X18301219"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,7]]},"references-count":16,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2018,7]]}},"alternative-id":["S1319562X18301219"],"URL":"https:\/\/doi.org\/10.1016\/j.sjbs.2018.05.010","relation":{},"ISSN":["1319-562X"],"issn-type":[{"value":"1319-562X","type":"print"}],"subject":[],"published":{"date-parts":[[2018,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"MicroRNA-4728 serves as a suppressor and antagonist of oncogenic MAPK in Burkitt lymphoma","name":"articletitle","label":"Article Title"},{"value":"Saudi Journal of Biological Sciences","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.sjbs.2018.05.010","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Production and hosting by Elsevier B.V. on behalf of King Saud University.","name":"copyright","label":"Copyright"}]}}